Ann Mari Holsæter
Stillingsbeskrivelse
Ann Mari Holsæter er førsteamanuensis ved Insitutt for farmasi (IFA), og forskningsgruppen Drug Transport and Delivery (DTD).
Ann Mari Holsæter er Cand Pharm fra 幸运大转盘 i 1999 med doktorgrad (Dr.Scient) fra samme institusjon i 2004.
I tillegg til lang akademisk karrierer ved 幸运大转盘 Norges Arktiske Universitet, har Holsæter også erfaring fra jobb i industrien, og som tidligere ansatt ved både ProBio Neutraceuticals AS (2006-2008) og Biotec Pharmacon ASA (2008-2011). Her hadde hun ulike roller inne kvalitetsorganisasjonene, inkludert Kvalitetssjef og QP
Hennes nåværende jobb som førsteamanuensis innebærer en 50/50 fordeling mellom forskning og undervisning. I tillegg til emneansvar og undervisning på alle nivå av farmasiutdanningen, veileder hun fortløpende både Master- og PhD studenter.
Laura Victoria Schulte-Werning,
Bhupender Singh,
Mona Susan Johannessen,
Rolf Einar Engstad,
Ann-Mari Hols忙ter
:
Antimicrobial liposomes-in-nanofiber wound dressings prepared by a green and sustainable wire-electrospinning set-up
International Journal of Pharmaceutics 2024 /
Jakob Tobias Lynnerup,
Jonas Borregaard Eriksen,
Annette Bauer-Brandl,
Ann Mari Hols忙ter,
Martin Brandl
:
Insight into the mechanism behind oral bioavailability-enhancement by nanosuspensions through combined dissolution/permeation studies
European Journal of Pharmaceutical Sciences 2023 /
Ann Mari Hols忙ter,
Kristina Wizgird,
Iselin Karlsen,
Jeanette Frimand Hemmingsen,
Martin Brandl,
Natasa Skalko-Basnet
:
How docetaxel entrapment, vesicle size, zeta potential and stability change with liposome composition鈥揂 formulation screening study
European Journal of Pharmaceutical Sciences 2022 /
Jostein Grip,
Erik Steene,
Rolf Einar Engstad,
Jeff Hart,
Andrea Bell,
Ingrid Skj忙veland
m.fl.:
Development of a novel beta-glucan supplemented hydrogel spray formulation and wound healing efficacy in a db/db diabetic mouse model
European journal of pharmaceutics and biopharmaceutics 2021 /
May Wenche J酶raholmen,
Selenia Ternullo,
Ann Mari Hols忙ter,
G酶ril Eide Flaten,
Natasa Skalko-Basnet
:
Advanced Drug Delivery Systems for Biologics
John Wiley & Sons 2021
Laura Schulte Werning,
Anjanah Murugaiah,
Bhupender Singh,
Mona Johannessen,
Rolf Einar Engstad,
Natasa Skalko-Basnet
m.fl.:
Multifunctional Nanofibrous Dressing with Antimicrobial and Anti-Inflammatory Properties Prepared by Needle-Free Electrospinning
Pharmaceutics 2021 /
Selenia Ternullo,
Laura Schulte Werning,
Ann Mari Hols忙ter,
Natasa Skalko-Basnet
:
Curcumin-In-Deformable Liposomes-In-ChitosanHydrogel as a Novel Wound Dressing
Pharmaceutics 2020 /
Jennifer Cauzzo,
Mona Nystad,
Ann Mari Hols忙ter,
Purusotam Basnet,
Natasa Skalko-Basnet
:
Following the fate of dye-containing liposomes in vitro
International Journal of Molecular Sciences 09. juli 2020 /
Selenia Ternullo,
Purusotam Basnet,
Ann Mari Hols忙ter,
G酶ril Eide Flaten,
Louis de Weerd,
Natasa Skalko-Basnet
:
Deformable liposomes for skin therapy with human epidermal growth factor: The effect of liposomal surface charge
European Journal of Pharmaceutical Sciences 2018 /
Jostein Grip,
Rolf Einar Engstad,
Ingrid Skj忙veland,
Natasa Skalko-Basnet,
Johan Isaksson,
Purusotam Basnet
m.fl.:
Beta-glucan-loaded nanofiber dressing improves wound healing in diabetic mice
European Journal of Pharmaceutical Sciences 2018 /
Ulrich Massing,
Sveinung Gaarden Ingebrigtsen,
Natasa Skalko-Basnet,
Ann Mari Hols忙ter
:
Dual Centrifugation - A Novel 鈥渋n-vial鈥 Liposome Processing Technique
IntechOpen 2017 /
Sveinung Gaarden Ingebrigtsen,
Natasa Skalko-Basnet,
Cristiane de Albuquerque Cavalcanti Jacobsen,
Ann Mari Hols忙ter
:
Successful co-encapsulation of benzoyl peroxide and chloramphenicol in liposomes by a novel manufacturing method - dual asymmetric centrifugation
European Journal of Pharmaceutical Sciences 2017 / /
Selenia Ternullo,
Louis de Weerd,
G酶ril Eide Flaten,
Ann Mari Hols忙ter,
Natasa Skalko-Basnet
:
The isolated perfused human skin flap model: A missing link in skin penetration
studies?
European Journal of Pharmaceutical Sciences 2017 /
Jostein Grip,
Rolf Einar Engstad,
Ingrid Skj忙rveland,
Natasa Skalko-Basnet,
Ann Mari Hols忙ter
:
Sprayable Carbopol hydrogel with soluble beta-1,3/1,6-glucan as an active ingredient for wound healing 鈥 Development and in-vivo evaluation
European Journal of Pharmaceutical Sciences 2017 /
Selenia Ternullo,
Louis de Weerd,
Ann Mari Hols忙ter,
G酶ril Eide Flaten,
Natasa Skalko-Basnet
:
Going skin deep: a direct comparison of penetration potential of lipid-based nanovesicles on the isolated perfused human skin flap model
European journal of pharmaceutics and biopharmaceutics 2017 /
Anders 脴verbye,
Ann Mari Hols忙ter,
Markus Fusser,
Natasa Skalko-Basnet,
Tore Geir Iversen,
Maria Lyngaas Torgersen
m.fl.:
Ceramide-containing liposomes with doxorubicin: time and
cell-dependent effect of C6 and C12 ceramide
OncoTarget 2017 /
Sveinung Gaarden Ingebrigtsen,
Alena Didriksen,
Mona Johannessen,
Natasa Skalko-Basnet,
Ann Mari Hols忙ter
:
Old drug, new wrapping 鈥 A possible comeback for chloramphenicol?
International Journal of Pharmaceutics 2017 /
Ann-Mari Hols忙ter
:
Beredskapsplaner: Hvilken rolle skal farmasiutdanningene spille?
Nordnorsk Debatt 23. januar 2025
Ann Mari Hols忙ter
:
Hvilken rolle skal farmasiutdanningene spille?
Nordlys 24. januar 2025
Ann Mari Hols忙ter
:
Beredskapsplaner: Hvilken rolle skal farmasiutdanningene spille?
Farmatid.no 24. januar 2025
Ann-Mari Hols忙ter
:
Beredskapsplaner: Hvilken rolle skal farmasiutdanningene spille?
Norsk Farmaceutisk Tidsskrift (NFT) 2025
Ann Mari Hols忙ter
:
Digital hverdag - Bruk av digitale verkt酶y i tilvirkning - Utdanningsperspektiv fra 幸运大转盘
2025
Abina Jeyachanderan,
Ann Mari Hols忙ter
:
Tidsbruk for implementering av BD Cato, Masteroppgave 幸运大转盘
2025
Laura Victoria Schulte-Werning,
Ivo Laim盲e,
Lisa Myrseth Hemmingsen,
Jyrki Hein盲m盲ki,
Liis Preem,
Karin Kogermann
m.fl.:
Core-Shell Nanofibers Prepared by Coaxial Electrospinning Challanged by Polyelectrolyte Complexation Between Chitosan and Pectin
2024
Ann-Mari Hols忙ter
:
Nanofibers to combat antimicrobial resistance 鈥 How and Why?
2024
Laura Victoria Schulte-Werning,
Ann-Mari Hols忙ter
:
Enhanced Stability and Topical Promise of Chloramphenicol in a Dry Dressing Format
2024
Agnhild Johansen,
Kjersti Sell忙g,
Synn酶ve Norvoll Magnussen,
May Wenche J酶raholmen,
Ann Mari Hols忙ter
:
Docetaxel liposomes 鈥 Can curcumin be co-entrapped and improve the in vitro cytotoxicity?
2023
Ann Mari Hols忙ter
:
Cancer and drug delivery
2023
Ann Mari Hols忙ter
:
N忙rings-Ph.d. prosjekt for utvikling av nye s氓rprodukter ga etablering av forskning p氓 nanofibre som legemiddelform i Norge
2022
Paul Gottschalk,
Ann Mari Hols忙ter
:
Optimierung der Herstellung von Liposomen mittels dualer
asymmetrischer Zentrifugation
2022
Jakob T. Lynnerup,
Jonas B. Eriksen,
Ann Mari Hols忙ter,
Martin Brandl
:
The effect of nano-milling on dissolution/permeation of poorly soluble drug compounds
2022
Laura Schulte Werning,
Natasa Skalko-Basnet,
Ann Mari Hols忙ter
:
Needle-free electrospinning of nanofibers with chloramphenicol-liposomes using the NanospiderTM
2022
Ann Mari Hols忙ter
:
Ann Mari Hols忙ter: - Etikk m氓 l忙res gjennom hele livet
01. mars 2021
Laura Schulte Werning,
Anjanah Murugaiah,
Natasa Skalko-Basnet,
Ann Mari Hols忙ter
:
In vitro testing of biocompatibility and anti-inflammatory activity of chloramphenicol loaded multifunctional nanofibers
2021
Laura Schulte Werning,
Anjanah Murugaiah,
Natasa Skalko-Basnet,
Ann Mari Hols忙ter
:
Electrospinning of chloramphenicol-containing nanofibrous dressings for treatment of chronic wounds
2021
Laura Schulte Werning,
Anjanah Murugaiah,
Natasa Skalko-Basnet,
Ann Mari Hols忙ter
:
Successful entrapment of chloramphenicol in electrospun nanofiber dressings
2021
Jeanette Frimand Hemmingsen,
Martin Brandl,
Natasa Skalko-Basnet,
Ann Mari Hols忙ter
:
Design, preparation, characterization and stability of
docetaxel-containing liposomes
2020
Laura Schulte Werning,
Julie Wik Olaussen,
Natasa Skalko-Basnet,
Ann Mari Hols忙ter
:
Electrospinning chitosan-nanofibers using the needle-free Nanospider鈩 technology; Optimization of the polymer solution
2020
Jennifer Cauzzo,
Mona Nystad,
Ann Mari Hols忙ter,
Purusotam Basnet,
Natasa Skalko-Basnet
:
Dyes in Disguise: characterization of fluorescently labeled liposomes
2020
Ann Mari Hols忙ter
:
Fokus p氓 utnyttelse av digitale l忙ringsressurser for 酶kt fleksibilitet og kvalitet i undervisningen av de farmas酶ytiske laboratoriefagene
2019
Jennifer Cauzzo,
Mona Nystad,
Ann Mari Hols忙ter,
Purusotam Basnet,
Natasa Skalko-Basnet
:
Liposome-cell interaction: following the fate of the nanocarrier
2019
Ann Mari Hols忙ter,
Kristina Wizgird,
Natasa Skalko-Basnet
:
Docetaxel-liposomes prepared by dual centrifugation: effect of propylene glycol and lipid charge
2019
Iselin Karlsen,
Natasa Skalko-Basnet,
Ann Mari Hols忙ter
:
Docetaxel Liposomes - A formulation Screening Study
2019
Jostein Grip,
Erik Steene,
Rolf Einar Engstad,
Ingrid Skj忙veland,
Purusotam Basnet,
Natasa Skalko-Basnet
m.fl.:
Sprayable beta-glucan hydrogel as wound dressing: in vitro and in vivo evaluation
2019
Ann Mari Hols忙ter,
Jostein Grip,
Natasa Skalko-Basnet
:
Advanced wound dressing with beta-glucans: in vivo proof of nanofibers superiority
2018
Ann Mari Hols忙ter
:
Vurdering av l忙ring i laboratorieundervisning 鈥 et eksempel fra farmasiutdanningen
2017
Ann Mari Hols忙ter,
Sveinung Gaarden Ingebrigtsen,
Natasa Skalko-Basnet
:
Dermal Application of Chloramphenicol - The Effect of Liposomes and Chitosan Hydrogel Formulations on ex vivo Permeation and Antimicrobial Activity
2017
Selenia Ternullo,
Louis de Weerd,
Ann Mari Hols忙ter,
G酶ril Eide Flaten,
Natasa Skalko-Basnet
:
A Nano-Approach to Improve Local Skin Therapy: Isolated Perfused Human Skin Flap as a Tool in Optimization
2017
Ann Mari Hols忙ter
:
New activities related to liposomes
2017
Jostein Grip,
Rolf Einar Engstad,
Ingrid Skj忙veland,
Natasa Skalko-Basnet,
Ann Mari Hols忙ter
:
Development of a novel wound healing spray: soluble beta-1,3/1,6-glucan as an active ingredient in Carbopol matrix in a db/db wound model
2017
Forskningsinteresser
Forskningen hennes har fokus på avanserte legemiddelformuleringer, og forbedring av legemiddelterapi gjennom forbedring av legemidlenes opptak, stabilitet og/eller spesifisitet, med reduserte bivirkninger og økt effekt av behandling som mål. Hun har særlig ekspertise og interesse for liposomer, nanofibre og hydrogeler, anvendt alene eller i kombinasjon. Disse formuleringen er i hennes tilfelle i hovedsak fremstilt for topikal (huden, og sårbehandling) og systemisk administrasjon (injeksjonsmedisin), og da gjerne med antimikrobiell, anti-cancer eller immunstimmulerende effekt som mål.
I forskningsgruppen har Ann Mari særlig ekspertise på teknologier som elektrospinning av nanofibre og bruk av "dual centrifugering" i fremstilling av nanopartikler, inkluderte liposomer.
Undervisning
Emner Ann Mari underviser i:
- FAR-2401; Legemiddelfremstilling og kvalitetskontroll (10 STP), underviser (emneansvarlig 2012-2019)
- FAR-2402; Legemiddelformulering og biofarmasi (10 STP)- emneansvarlig siden 2019, underviser siden 2012
- FAR-3401; Advansert legemiddelteknologi og biofarmasi (10 STP), foreleser
- FAR-3911; Masteroppgave i farmasi (50 STP), veileder
- FAR-3043: Nanomedisin (15 STP), foreleser
- FAR-8043; Nanomedicine and nanotechnology (15 STP), foreleser
